Cannabidiol for severe childhood epilepsy
Treatments studied
Part of Brain & nervous system clinical trials.
This trial provides access to cannabidiol (CBD), a marijuana-derived compound, for children with severe epilepsy that hasn't improved with standard medications. The goal is to see if CBD can help reduce seizures in this difficult-to-treat group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 5 to 19 years old
- Seizures not controlled by at least three different anti-seizure medicines
- On 1 to 3 anti-seizure medicines at the same dose for at least 4 weeks before starting
- Significant developmental delays, such as not speaking and not walking without help
- No use of CBD or other cannabis products for at least 1 month before starting
- Must be able to attend all study visits and follow study rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a cannabis-based medicine can reduce seizures in people with epilepsy that hasn't improved with other treatments. It may offer a new option for those who continue to have seizures.
This trial studies how well a ketogenic diet works for children with hard-to-treat epilepsy or certain other diseases. It aims to see if the diet improves quality of life.
This trial tests an oral cannabidiol medicine (Epidiolex) for children whose seizures are not controlled by other treatments. It aims to see if adding this drug can reduce seizure frequency.
This trial tests if adding cannabidiol (CBD) to your child's current seizure medicines can reduce seizures. It uses a personalized approach to see if CBD works for each child.
This trial tests whether a medication called cannabidiol (a cannabis-derived compound) can reduce severe self-injury behaviors in children and teens with severe neurodevelopmental disorders. It aims to see if it's safe and effective when other treatments haven't worked.
This study looks at what happens when children with Dravet or Lennox Gastaut syndrome switch from a homemade or artisanal CBD product to Epidiolex, a prescription CBD. The goal is to see if the switch is safe and helps control seizures.
Hear when a new Drug Resistant Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.